Endothelial arginase 2 mediates retinal ischemia/reperfusion injury by inducing mitochondrial dysfunction
Objective: Retinal ischemic disease is a major cause of vision loss. Current treatment options are limited to late-stage diseases, and the molecular mechanisms of the initial insult are not fully understood. We have previously shown that the deletion of the mitochondrial arginase isoform, arginase 2...
Saved in:
Main Authors: | Esraa Shosha (Author), Abdelrahman Y. Fouda (Author), Tahira Lemtalsi (Author), Stephen Haigh (Author), David Fulton (Author), Ahmed Ibrahim (Author), Mohamed Al-Shabrawey (Author), R. William Caldwell (Author), Ruth B. Caldwell (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NOX2-Induced Activation of Arginase and Diabetes-Induced Retinal Endothelial Cell Senescence
by: Modesto Rojas, et al.
Published: (2017) -
Arginase Pathway in Acute Retina and Brain Injury: Therapeutic Opportunities and Unexplored Avenues
by: Abdelrahman Y. Fouda, et al.
Published: (2020) -
The role of arginase in endothelial dysfunction
by: Rudolf Lucas
Published: (2015) -
Hepatic Ischemia-Reperfusion Impairs Blood-Brain Barrier Partly Due to Release of Arginase From Injured Liver
by: Liang Zhu, et al.
Published: (2021) -
USE OF SELECTIVE INHIBITORS OF ARGINASE 2 AND TADALAFIL IN COMBINED COMPENSATION OF HOMOCYSTEINE-INDUCED ENDOTHELIAL DYSFUNCTION
by: Ivan Koklin
Published: (2015)